Medindia LOGIN REGISTER
Medindia

Novel Treatment Delivery for Robotic Radiosurgery System Identified

by Sheela Philomena on Oct 4 2011 11:06 AM

A recent study reports the presence of an alternative method to the conventional CyberKnife treatment delivery system.

 Novel Treatment Delivery for Robotic Radiosurgery System Identified
A recent study reports the presence of an alternative method to the conventional CyberKnife treatment delivery system. CyberKnife is one of the radiosurgery procedures which focus beams of high-energy X-rays to target tumors and other abnormalities in the body. The alternative method uses a multileaf collimator (MLC) and can flexibly sculpt a single radiation beam to match the exact contour of a tumor––significantly reducing the treatment time and minimizing the amount of radiation to the neighboring tissues.
Jiajin Fan, Ph.D., a radiation oncology physicist at Fox Chase, will present the study at the 2011 American Society for Radiation Oncology Annual Meeting on Sunday, October 2.

In the study, Fan and his team compared treatment plans created with the CyberKnife MLC (CK-MLC) delivery device to the original IRIS cone collimator device, and to Intensity-Modulated Radiation Therapy (IMRT) plans, which also precisely shapes radiation beams to conform to the shape of a tumor. When these techniques were applied for five patients with various tumors, all of them had good target dose coverage.However, radiation doses fell off most sharply in the CK-MLC plan, which was associated with the greatest sparing of the surrounding structures, such as the rectum and bladder for a prostate cancer patient compared to the IRIS plan. In addition, the delivery of the CK-MLC treatment plan took only10 minutes which is about 10 percent of the total IRIS plan treatment time . This is primarily because the number of beams required is significantly less with the CK-MLC technique.

"Using the MLC plan, we can deliver radiation therapy much faster compared to the current CyberKnife technique, and we can achieve much better target coverage and a much sharper dose fall off than a regular IMRT plan," Fan says. "Basically, we can spare the critical structures around tumors much better , providing the ability to treat the tumor to a higher dose without increasing the normal tissue toxicity . Consequently, we can achieve better tumor control with less damage to the patient's body." The advantages associated with the CK-MLC plan offer great potential for the widespread clinical application of robotic radiotherapy, Fan adds.

Source-Eurekalert


Advertisement